EPS for Quintiles IMS Holdings Inc (Q) Expected At $1.03

July 18, 2017 - By Dolores Ford

 EPS for Quintiles IMS Holdings Inc (Q) Expected At $1.03
Investors sentiment increased to 1.75 in Q4 2016. Its up 1.00, from 0.75 in 2016Q3. It improved, as 39 investors sold Quintiles IMS Holdings Inc shares while 93 reduced holdings. 85 funds opened positions while 146 raised stakes. 216.20 million shares or 97.25% more from 109.60 million shares in 2016Q3 were reported.
9,980 are owned by Chicago Equity Ltd. Westpac Banking, Australia-based fund reported 112,171 shares. Metropolitan Life Insur holds 0% or 8,522 shares in its portfolio. Fjarde Ap stated it has 45,551 shares or 0.08% of all its holdings. Paloma Prtn Mgmt stated it has 5,728 shares. Hsbc Public Limited accumulated 0.1% or 559,966 shares. 526 are owned by Bluemountain Cap Management Llc. Dimensional Fund Advsr Limited Partnership holds 423,601 shares. Cantab Capital Partners Ltd Liability Partnership has 17,019 shares for 0% of their portfolio. Steinberg Asset Ltd Liability Company accumulated 202,319 shares. Meeder Asset Mngmt Incorporated accumulated 18,568 shares. Highstreet Asset Management has 10,279 shares. 5,500 are held by Arizona State Retirement System. Moreover, Dupont Management Corporation has 0.17% invested in Quintiles IMS Holdings Inc (NYSE:Q). Moreover, Hirtle Callaghan & Company Limited Liability Corp has 0% invested in Quintiles IMS Holdings Inc (NYSE:Q) for 28 shares.

Wall Street await Quintiles IMS Holdings Inc (NYSE:Q) to release earnings on July, 26. Analysts forecast earnings per share of $1.03, up exactly $0.10 or 10.75 % from 2014’s $0.93 EPS. The expected Q’s profit could reach $222.74 million giving the stock 21.86 P/E in the case that $1.03 earnings per share is reported. After posting $1.01 EPS for the previous quarter, Quintiles IMS Holdings Inc’s analysts now forecast 1.98 % EPS growth. The stock increased 0.78% or $0.7 during the last trading session, reaching $90.08. About 958,313 shares traded or 0.41% up from the average. Quintiles IMS Holdings Inc (NYSE:Q) has risen 27.93% since July 18, 2016 and is uptrending. It has outperformed by 11.23% the S&P500.

Quintiles IMS Holdings Inc (NYSE:Q) Ratings Coverage

Among 18 analysts covering Quintiles Transnational (NYSE:Q), 5 have Buy rating, 0 Sell and 13 Hold. Therefore 28% are positive. Quintiles Transnational had 36 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Zacks to “Buy” on Tuesday, August 25. As per Friday, October 14, the company rating was initiated by Stifel Nicolaus. As per Friday, December 2, the company rating was downgraded by Bank of America. Goldman Sachs initiated the stock with “Buy” rating in Wednesday, October 5 report. Mizuho initiated the shares of Q in report on Tuesday, December 13 with “Neutral” rating. The company was upgraded on Friday, February 17 by Wells Fargo. On Friday, September 4 the stock rating was downgraded by Zacks to “Hold”. The stock has “Hold” rating by Deutsche Bank on Friday, February 3. As per Wednesday, May 4, the company rating was downgraded by Evercore. Zacks upgraded Quintiles IMS Holdings Inc (NYSE:Q) on Thursday, August 27 to “Hold” rating.

Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The company has market cap of $19.48 billion. The Firm operates through divisions, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. It has a 81.66 P/E ratio. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

More important recent Quintiles IMS Holdings Inc (NYSE:Q) news were published by: Prnewswire.com which released: “Today’s Research Report Coverage on Medical Labs Stocks — Agilent …” on July 12, 2017, also Nasdaq.com published article titled: “Q Crosses Above Average Analyst Target”, Seekingalpha.com published: “Quintiles IMS: A Novel Way To Invest In Biopharma” on July 17, 2017. More interesting news about Quintiles IMS Holdings Inc (NYSE:Q) was released by: Reuters.com and their article: “Quintiles IMS explores sale of contract sales business: sources” with publication date: June 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.